of 0.08 m-cytochrome c, reduced with NaBH,, in 75m-sodium phosphate buffer, pH 7.5); the bulk of the activity was recovered in band (a), with a fivefold increase in specific activity, and there was little or no activity in the other bands.
Elevation of Intracellular Calcium Ion Concentration Provokes Production of l,%Diacylglycerol and Phosphatidate in Human Erythrocytes
Treatment of human erythrocytes with the ionophore A23187 (1 pglml) caused a rapid rise in the concentration of 1 ,2-diacylglycerol in the cells: this effect was dependent on the presence of CaZ+ in the extracellular medium. In cells incubated with compound A23187 and Caz+ for 1 h the accumulated 1,2-diacylglycerol constituted 1-2% of the glycerolipids, as compared with about 0.2 % in untreated cells. There was also a 5-10-fold increase in the rate of 32P incorporation into phosphatidate in ionophore-treated cells: no other phospholipids were appreciably labelled under these conditions. The ATP content of erythrocytes fell rapidly within a few minutes after the addition of compound A23187, but only a small proportion of the lost ATP could have been used for phosphatidate synthesis; the remainder was presumably hydrolysed by the activated Caz+-stimulated ATPase(s) (adenosine triphosphate) of the compound A231 87-treated erythrocytes.
The diacylglycerol kinase of the erythrocyte membrane, which was presumably responsible for the synthesis of phosphatidate under these conditions, was not directly stimulated by the addition of CaZ+. The increased synthesis of phosphatidate was therefore a secondary effect which was due to increased availability of 1,2-diacylglycerol in cells in which the intracellular Caz+ was increased. This interpretation was confinned
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BIOCHEMICAL SOCIETY TRANSACTIONS when it was observed that even larger increases in phosphatidate labelling could be provoked by adding 1,2-diacylglycerol to erythrocytes through the action of a non-lytic concentration (1 .ug/ml) of Clostridium perfringens phospholipase C on the cells. In this case there was an increase of several hundredfold in the incorporation of 3zP, into phosphatidate and in these cells phosphatidate constituted up to 12% of the total phospholipids.
Thus the increase in intracellular CaZ+ caused by treatment of erythrocytes with compound A231 87 leads to production of 1 ,2-diacylglycerol, probably at the inner surface of the plasma membrane, and this is followed by its conversion into phosphatidate with intracellular ATP as the phosphate donor. In contrast, treatment of intact erythrocytes with phospholipase C would initially add diacylglycerol to the outer leaflet of the lipid bilayer in the membranes. However, this diacylglycerol is also rapidly converted into phosphatidate; presumably it has first to diffuse across the membrane to gain access to intracellular ATP and diacylglycerol kinase.
Each experimental condition that leads to increased concentrations of 1,2-diacylglycerol and phosphatidate in the erythrocyte membrane also leads to one of two types of characteristic morphological effect on the cells. Phospholipase C treatment, which adds diacylglycerol to the outer leaflet of the membrane, induces invagination and inward vesiculation, whereas compound A23 187 plus Caz+, which adds diacylglycerol to the inner leaflet, leads to evagination and probably to outward vesiculation. 1 ,2-Diacylglycerol, which may have a central role in initiating these morphological changes, has previously been reported to be an effective membrane-fusing agent in model systems in vitro. Possibly the morphological effects produced by intracellular Caz+ in more normal physiological situations (e.g. hormone-stimulated exocytosis) are determined by the influence of 1 ,2-diacylglycerol on membranemembrane interactions. If this were so then the role of the high diacylglycerol kinase of erythrocytes might be to defend the cell against accumulation of diacylglycerol and its consequences.
The source of the diacylglycerol which is produced in response to increase in intracellular Ca2+ is yet to be established. Its fatty acid composition is very similar to that of the phosphatidylcholine of human erythrocytes and it seems possible that it may be produced from this by the action of a Caz+-activated phospholipase C. However, neither this activity nor any other which would lead to production of 1,2-diacylglycerol has yet been described in erythrocytes.
Treatment with compound A23187 and Caz+ also leads to rapid synthesis of phosphatidate, and secondarily of phosphatidylinositol, in pig lymphocytes, suggesting that production of 1,2-diacylglycerol in response to elevation of intracellular CaZ+ is not confined to erythrocytes. for valuable discussions. 
